Press Releases

Date	Title	Company
02-Dec-2022	Cell Culture Market Report Covers Trends, Demand, Growth, and Forecast 2032	MARKITWIRED
02-Dec-2022	Hospital Capacity Management Solutions Market: Advanced R&D Process Strategies 2022-2030	MARKITWIRED
02-Dec-2022	Injection Pen Market Detail Analysis of Current and Future Projection 2022-2032	MARKITWIRED
02-Dec-2022	In Vitro Fertilization Market Will Generate Booming Growth Opportunities to 2032	MARKITWIRED
02-Dec-2022	Molecular Quality Controls Market Competitive Landscape, Innovations and Business Outlook till 2032	MARKITWIRED
02-Dec-2022	RNA Sequencing Services Market, 2035 - ResearchAndMarkets.com	Businesswire
02-Dec-2022	The Worldwide Hydrogen Peroxide Industry is Projected to Reach $4 Billion by 2027 - ResearchAndMarkets.com	Businesswire
02-Dec-2022	Almirall joins FACILITATE, a patient-driven Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants	Almirall
02-Dec-2022	Eisai presents full results of lecanemab Phase 3 confirmatory Clarity AD study for early Alzheimer’s	Eisai
02-Dec-2022	BioXcel Therapeutics Announces First Patients Dosed in SERENITY III Phase 3 Trial for Acute Treatment of Agitation in Adults with Bipolar I or II Disorder or Schizophrenia	BioXcel Therapeutics
02-Dec-2022	Global Pulmonary Drug Delivery Devices Market Report to 2031 - Players Include Boehringer Ingelheim, Novartis, Mylan and 3M - ResearchAndMarkets.com	Businesswire
02-Dec-2022	Achilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022	Achilles Therapeutics
02-Dec-2022	Diphtheria outbreak – the Government must drop its complacency and step-up testing, warns expert	Diphtheria outbreak – the Government must drop its complacency and step-up testing, warns expert
02-Dec-2022	VPM1002 Vaccination as Prophylaxis Against Severe Respiratory Infectious Diseases	VPM1002 Vaccination as Prophylaxis Against Severe Respiratory Infectious Diseases
02-Dec-2022	Veeva Pulse Shows Europe HCP Access Averages 52% with Largest Growth in Content-Driven Digital Engagement Worldwide	Veeva Pulse Shows Europe HCP Access Averages 52% with Largest Growth in Content-Driven Digital Engagement Worldwide
02-Dec-2022	Aptamer Group announces new deals to support novel therapies and improved assays	Aptamer Group announces new deals to support novel therapies and improved assays
02-Dec-2022	Brooklands Innovation Academy inspires 400 STEM students	Brooklands Innovation Academy
02-Dec-2022	Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors	Immunocore
02-Dec-2022	SmiLe strengthens team with international business expertise	SmiLe
02-Dec-2022	Stoke Therapeutics Presents Data from a Combined Interim Analysis of the Phase 1/2a MONARCH and ADMIRAL Studies of STK-001 in Children and Adolescents with Dravet Syndrome at the American Epilepsy Society (AES) 2022 Annual Meeting	Businesswire